My bookmarksSign up free
Source

Council Decision (EU) 2022/86 of 17 January 2022 on the position to be adopted on behalf of the European Union within the EEA Joint Committee concerning the amendment of Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement (Text with EEA relevance)

Council Decision (EU) 2022/86 of 17 January 2022 on the position to be adopted on behalf of the European Union within the EEA Joint Committee concerning the amendment of Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement (Text with EEA relevance)

Decision (EU) 2022/86 · Decision · 2 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The position to be adopted on the Union’s behalf within the EEA Joint Committee concerning the amendment of Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement shall be based on the draft Decision of the EEA Joint Committee attached to this Decision  ( 5 ) .

Article 2

Open ↗

This Decision shall enter into force on the date of its adoption.

Other acts of the same type
Council Decision (CFSP) 2021/1305 of 5 August 2021 amending Decision 2010/638/CFSP concerning restrictive measures against the Republic of GuineaCouncil Implementing Decision (CFSP) 2021/1306 of 5 August 2021 implementing Decision 2012/285/CFSP concerning restrictive measures directed against certain persons, entities and bodies threatening the peace, security or stability of the Republic of Guinea-BissauCommission Implementing Decision (EU) 2021/1299 of 4 August 2021 postponing the expiry date of approval of hexaflumuron for use in biocidal products of product-type 18 (Text with EEA relevance)Decision (EU) 2021/1437 of the European Central Bank of 3 August 2021 amending Decision (EU) 2017/934 on the delegation of decisions on the significance of supervised entities (ECB/2021/33)Decision (EU) 2021/1438 of the European Central Bank of 3 August 2021 amending Decision (EU) 2017/935 on delegation of the power to adopt fit and proper decisions and the assessment of fit and proper requirements (ECB/2021/34)Decision (EU) 2021/1439 of the European Central Bank of 3 August 2021 amending Decision (EU) 2018/546 on delegation of the power to adopt own funds decisions (ECB/2021/35)Decision (EU) 2021/1440 of the European Central Bank of 3 August 2021 amending Decision (EU) 2019/1376 on delegation of the power to adopt decisions on passporting, acquisition of qualifying holdings and withdrawal of authorisations of credit institutions (ECB/2021/36)Decision (EU) 2021/1441 of the European Central Bank of 3 August 2021 amending Decision (EU) 2019/322 on delegation of the power to adopt decisions regarding supervisory powers granted under national law (ECB/2021/37)Decision (EU) 2021/1442 of the European Central Bank of 3 August 2021 on delegation of the power to adopt decisions on internal models and on extension of deadlines (ECB/2021/38)Commission Implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)Commission Implementing Decision (EU) 2021/1284 of 2 August 2021 postponing the expiry date of approval of aluminium phosphide for use in biocidal products of product-types 14 and 18 (Text with EEA relevance)Commission Implementing Decision (EU) 2021/1285 of 2 August 2021 postponing the expiry date of approval of magnesium phosphide for use in biocidal products of product-type 18 (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next